{"url_path":"/sec/mnov/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1226616/0001193125-26-224066-index.html","accession_number":"0001193125-26-224066","cik":"0001226616","ticker":"MNOV","issuer_name":"MEDICINOVA INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1226616/0001193125-26-224066-index.html","primary_entity_key":"0001226616","primary_entity_name":"MEDICINOVA INC"},"word_count":366,"has_tables":true,"body_markdown":"ITEM 6. EXHIBITS.\n\n \n\nExhibit\n\nNumber\n\n \n\nDescription\n\n \n\n \n\n \n\n3.1\n\n[Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 9, 2012 (File No. 001-33185)).](https://www.sec.gov/Archives/edgar/data/1226616/000119312512347932/d344794dex31.htm)\n\n3.2\n\n[Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on April 25, 2019 (File No. 001-33185)).](https://www.sec.gov/Archives/edgar/data/1226616/000119312519119751/d727763dex31.htm)\n\n \n\n \n\n \n\n31.1(1)\n\n \n\n[Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](mnov-ex31_1.htm)\n\n \n\n \n\n \n\n31.2(1)\n\n \n\n[Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](mnov-ex31_2.htm)\n\n \n\n \n\n \n\n32.1(1)*\n\n \n\n[Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002).](mnov-ex32_1.htm)\n\n \n\n \n\n \n\n32.2(1)*\n\n \n\n[Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002).](mnov-ex32_2.htm)\n\n \n\n \n\n \n\n101.INS(1)\n\n \n\nInline XBRL Instance Document - The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.\n\n \n\n \n\n \n\n101.SCH(1)\n\n \n\nInline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.\n\n \n\n \n\n \n\n104(1)\n\n \n\nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n \n\n(1)\nFiled Herewith\n\n*\n\nThe certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of MediciNova, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.\n\n23\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n \n\nMEDICINOVA, INC.\n\n \n\n \n\n \n\n \n\nDate: May 14, 2026\n\n \n\nBy:\n\n/s/ YUICHI IWAKI\n\n \n\n \n\n \n\nYuichi Iwaki, M.D., Ph.D.\n\n \n\n \n\n \n\nPresident and Chief Executive Officer\n\n \n\n \n\n \n\n(on behalf of the registrant and\n\n \n\n \n\n \n\nas the registrant’s Principal Executive Officer)\n\n \n\n \n\n \n\n \n\n \n\n \n\nBy:\n\n/s/ JASON KRUGER\n\n \n\n \n\n \n\nJason Kruger\n\n \n\n \n\n \n\nChief Financial Officer\n\n \n\n \n\n \n\n(on behalf of the registrant and\n\n \n\n \n\n \n\nas the registrant’s Principal Financial Officer)\n\n \n\n24"}